IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 252 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $5,127,437 | +7.0% | 481,902 | +5.8% | 0.31% | +4.0% |
Q1 2023 | $4,790,966 | +89668.9% | 455,415 | +5.7% | 0.30% | +2.7% |
Q4 2022 | $5,337 | -99.9% | 430,775 | +21.3% | 0.29% | +26.7% |
Q3 2022 | $3,678,000 | +0.5% | 355,050 | +11.9% | 0.23% | +5.5% |
Q2 2022 | $3,658,000 | +11.9% | 317,226 | +22.0% | 0.22% | +31.7% |
Q1 2022 | $3,270,000 | -66.1% | 259,943 | -68.6% | 0.17% | -51.2% |
Q4 2021 | $9,651,000 | -17.3% | 827,733 | -7.3% | 0.34% | -18.4% |
Q3 2021 | $11,663,000 | – | 893,070 | – | 0.42% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
EMC Capital Management | 43,315 | $417 | 0.31% |